The Trump administration has ordered federal prisons to begin reducing hormone therapy for incarcerated transgender people. The move, which doctors are calling 'dangerous' and could cause immediate psychological distress and long-term medical harm on a vulnerable population. The Federal Bureau of Prisons issued guidance on how the federal prison system will treat those diagnosed with gender dysphoria. It also prohibits the agency from initiating hormone therapy on inmates who were not already receiving it. The policy follows a January 2025 executive order from President Donald Trump barring federal funds from being used for medical treatments to align a person’s physical characteristics with a gender identity different from their sex assigned at birth. Critics argue that this violates the constitutional requirement that people to receive adequate medical health care in prison. The new policy may exacerbate existing conditions for transgender people already at heightened risk of violence.